New COVID Vaccines from Pfizer, Moderna and Novavax will Likely Protect Against Eris Variant

New COVID vaccines from Pfizer, Moderna and Novavax will likely provide protection against the new “Eris” variant, now the dominant strain of the virus in the U.S. Health experts and initial data suggest that the new shots will still be effective against Eris, or EG.5, and other widely circulating variants – all of which are descendants of omicron. 

All three companies are still waiting for FDA to approve their vaccines, meaning the vaccines won’t be available to the public for a month or so. The CDC must also decide which Americans should get the shots and how often. Read more from CNBC here.